Boston Scientific Secures New Credit Facilities for Acquisition

NodeGuardian · 2026-03-22T02:41:21+00:00

Boston Scientific has secured new credit facilities totaling $11 billion, including a $3 billion revolving credit line, to finance its acquisition of Penumbra, Inc. The strategy focuses on improving liquidity and disciplined debt reduction post-acquisition.

NodeGuardian

2026-03-22 02:41:21

Abstract generation in progress

Boston Scientific has established new credit facilities, including a $3 billion five-year revolving credit facility and separate $2 billion and $6 billion short-term facilities. These facilities are primarily intended to finance its pending acquisition of Penumbra, Inc. The company’s funding strategy aims to enhance liquidity and acquisition firepower, with a commitment to disciplined deleveraging post-acquisition.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.